Rubin Lab

University of Chicago

RUBIN LAB

University of Chicago

RUBIN LAB

MISSION STATEMENT FOR THE DIGESTIVE DISEASES CENTER

 

The Digestive Diseases Center at the University of Chicago Medicine is a collaborative, multidisciplinary network of physicians, researchers, and allied health professionals who share a legacy of innovation and a common purpose: to improve the lives of patients who suffer from digestive diseases.

University of Chicago Medicine and Biological Sciences

RUBIN LAB

David T. Rubin, MD, specializes in the treatment and assessment of digestive diseases. His clinical expertise includes inflammatory bowel diseases (Crohn’s disease and ulcerative colitis) and high-risk cancer syndromes.

RESEARCH

Find out about recent publications and ongoing clinical trials.

 

Rubin Lab at Digestive Disease Week 2025

 

Dr. Alvin George presented on applications of machine learning models in IBD

Khushi Bhondwe and Charlotte Duty presented on the association of mild hyperemia and biochemical disease activity despite the absence of bowel wall thickening on intestinal ultrasound

Alexandra McDermott presented on the clinical and biochemical effectiveness of dual-targeted therapy with risankizumab and upadacitinib in medically complex Crohn’s disease

Dr. Meredith Kline presented on the incidence and prophylaxis of VTE in pediatric patients with IBD

Dr. Asher Shafrir presented on the association between anti-TNF therapy and reduced risk of diabetes in patients with IBD

Jordan Karpin presented on the differences in depression, anxiety, and microbiome among female patients with IBD in two phases of the menstrual cycle

Dr. Agnes Ho presented on the real world experience of upadacitinib reinduction and high dose maintenance therapy to recapture disease response in IBD